Complix to Present at Upcoming BioEquity Europe 2013: http://t.co/jzPUX0k7Bp
posted
FlandersBio offers an up-to-date life sciences database containing all the life sciences companies with biotech activity in Flanders, and all FlandersBio members. The guide provides easy and fast access to the local life sciences community.
Life Sciences Database filtered on CNS, Brain
You can also perform a new search
Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies®, a novel class of therapeutic proteins based on single-domain antibody fragments, for a range of serious and life-threatening...
ADx NeuroSciences is a new biotech company focusing on the development of novel (bio)markers for use in dementia diagnosis (Dx) - for Alzheimer’s (AD), Parkinson’s and other neurodegenerative diseases - and the...
The objective of the company is to bring its first drug candidate to the clinic in 2 years. AlzProtect will develop its candidates up to clinical phase 2a before licensing them to a Pharma partner for further...
Cenix BioScience conducts contract research and technology development focused on cell-based and in vivo applications of RNAi, miRNA modulation and high content phenotyping to accelerate the discovery and validation of...
Founded as a spin-off of the “Université Libre de Bruxelles”, Euroscreen initially develops and commercializes G Protein-Coupled Receptors (GPCR) reagents. Euroscreen is now developing a pipeline of preclinical...
Galapagos is a mid-size biotechnology company specialized in the discovery and development of small molecule and antibody therapies with novel modes-of-action. The Company is progressing GLPG0634, as well as one of the...
icoMetrix offers the advanced image processing that is needed for quantitative analysis of biomedical images. Whether it be for a single patient or large-scale comparative group analysis, advanced image processing...
Innogenetics is an international biotechnological company that develops and markets diagnostic products to improve therapy management and patient health. Innogenetics develops and markets a wide range of diagnostic...
Janssen Pharmaceutica and other companies on our campus are part of the worldwide Janssen Pharmaceutical Group. Medicinal drugs for the benefit of patients, doctors and other health care professionals are discovered,...
Pfizer discovers, develops, manufactures and markets leading medicines for humans and animals. Their value-added products improve the quality of life of people around the world. Pfizer is a research based pharmaceutical...
The CNS Company PharmaNeuroBoost has two proprietary products in late clinical development stage: the antidepressant (AD) PNB01 in Phase III and the antipsychotic PNB02 in Phase IIa. The PNB01 phase III program is...
ReGenesys is a biopharmaceutical company focused on the research and development of stem cell based therapies. ReGenesys is a wholly-owned subsidiary of Athersys, a publicly held biotechnology company located in...
reMYND actively drives the development of disease modifying treatments against Alzheimer’s disease (AD), Parkinson’s disease (PD), and diabetes, either as a Contract Research Organisation (CRO) or through its own drug...
Synaptix was founded to become a leading European player in the field of active implantable medical devices (AIMD). Our mission is to evoke a paradigm shift in the neurostimulation field. With the introduction of our...
Therabel invests in Phase 3 clinical trials of new molecules developed by reliable partners, and in the development of new galenic forms and indications of existing molecules. It has a single up-to-date production site...
Toxikon contract laboratory provides comprehensive services for all stages of product development, from concept to final product. The scientific approach of our experienced staff provides customised studies for the...
UCB’s goal is to command a leading position in discovering and developing new therapies to treat patients suffering from severe diseases. With one of the strongest pipelines in the sector, their focus is on central...
